Alamar Biosciences Inc Cl A (ALMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 30,002 | 26,770 |
| Marketable Securities | N/A | 52,849 |
| Receivables | 12,753 | 6,648 |
| Inventories | 38,482 | 14,408 |
| Other current assets | 0 | 413 |
| TOTAL | $94,705 | $106,697 |
| Non-Current Assets | ||
| PPE Net | 10,498 | 7,523 |
| Intangibles | 1,988 | 2,044 |
| Other Non-Current Assets | 32,801 | 33,247 |
| TOTAL | $45,287 | $42,814 |
| Total Assets | $139,992 | $149,511 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 5,872 | 6,187 |
| Accrued Expenses | 15,759 | 8,493 |
| TOTAL | $23,730 | $16,591 |
| Non-Current Liabilities | ||
| Long Term Debt | 9,810 | N/A |
| Other Non-Current Liabilities | 30,410 | 31,335 |
| TOTAL | $40,220 | $31,335 |
| Total Liabilities | $63,950 | $47,926 |
| Shareholders' Equity | ||
| Common Shares | 1 | 1 |
| Retained earnings | -168,775 | -138,956 |
| Other shareholders' equity | 234,924 | 235,145 |
| TOTAL | $76,042 | $101,585 |
| Total Liabilities And Equity | $139,992 | $149,511 |